Arvee Laboratories (India) Limited

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹158.01
Market cap
174 Cr
Stock P/E
68.9
P/B
5.15

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2025Jun 2025Sept 2025
Sales6 Cr7 Cr3 Cr
Operating expenses (approx.)6 Cr7 Cr3 Cr
EBITDA0.43 Cr0.51 Cr0.36 Cr
OPM %6.7%6.8%10.3%
Other income0.21 Cr0.17 Cr0.23 Cr
Interest0.07 Cr0.04 Cr0.04 Cr
Depreciation0.27 Cr0.29 Cr0.30 Cr
Profit before tax0.09 Cr0.17 Cr0.01 Cr
Tax %26.3%2.9%1.9%
Net profit0.07 Cr0.17 Cr0.01 Cr
EPS (₹)₹0.06₹0.15₹0.01

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025TTM
Sales38 CrSign in for TTM
Operating expenses (approx.)34 CrSign in for TTM
EBITDA4 CrSign in for TTM
OPM %11.1%Sign in for TTM
Other income0.66 CrSign in for TTM
Interest0.25 CrSign in for TTM
Depreciation1 CrSign in for TTM
Profit before tax3 CrSign in for TTM
Tax %25.2%Sign in for TTM
Net profit2 CrSign in for TTM
EPS (₹)₹1.95Sign in for TTM
Dividend payout %0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025
Equity capital11 Cr
Reserves20 Cr
Borrowings
Other liabilities7 Cr
Total liabilities38 Cr
Fixed assets (net)15 Cr
CWIP0.73 Cr
Investments0.0000 Cr
Other assets22 Cr
Total assets38 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025
Cash from operating activity-0.04 Cr
Cash from investing-1 Cr
Cash from financing-0.21 Cr
Net cash flow-2 Cr
Free cash flow (OCF − Capex)-2 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025
ROCE %10.0%
ROE %6.9%
Debtor days
Inventory days88
Days payable
Cash conversion cycle88
Debt / equity
Current ratio4.75
Net debt / EBITDA-0.05